Loading insider details...
Beta
Latest Form 4 (Sep 22, 2026): Tax Withholding of 21,459 RNA shares, $192.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | Atrium Therapeutics, Inc. (RNA) | Tax Withholding | 21,459 | $192.1K |
| Apr 22, 2026 | Atrium Therapeutics, Inc. (RNA) | Grant/Award | 30,000 | n/a |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | Disposition to Issuer | 115,857 | n/a |
| Jan 23, 2026 | Avidity Biosciences, Inc. (RNA) | Sale | 2,017 | $146.1K |
| Jan 9, 2026 | Avidity Biosciences, Inc. (RNA) | Sale | 2,373 | $171.4K |
| Oct 24, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 2,209 | $22.4K |
| Sep 23, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 2,208 | $22.4K |
| Sep 17, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 1,542 | $10.1K |
| Aug 22, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 2,208 | $22.4K |
| Aug 15, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 1,542 | $10.1K |